Category: Clinical Trial Update Region: Asia · Japan Company: Daiichi Sankyo Chemical Pharma Co Ltd

Daiichi Sankyos Quizartinib Plus Chemotherapy Improves Os Compared To Chemotherapy In Patients With Newly Diagnosed Flt3-Itd Positive Aml

By, Admin 1 min read
Share
Daiichi Sankyos Quizartinib Plus Chemotherapy Improves Os Compared To Chemotherapy In Patients With Newly Diagnosed Flt3-Itd Positive Aml
Positive Results From The Global Pivotal Quantumfirst Phase 3 Trial Of Daiichi Sankyo

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!